Overview


According to FutureWise analysis the market for ai-based surgical robots is expected to reach US$ 36.5 billion by 2031 at a CAGR of 18.7%.

AI–based surgical robot, also known as surgical robot systems, is advanced medical devices that integrate artificial intelligence and advanced robotic technologies to assist surgeons during various surgical procedures. They have potentially revolutionized the field of surgery by increasing benefits like improved patient outcomes, enhanced surgeon training, reduced recovery times, and increased accuracy. It is significantly effective in laparoscopic and robotic surgery, where a video screen can display information or guidance from AI during the operation. It will effectively analyse the surgeries as they are being done and potentially support surgeons as they have been operating.

Key features which can be seen in the AI are robotic arms, i.e., it consists of multiple robotic arms which are well equipped with surgical instruments and cameras; AI algorithms that are integrated into the system to process amounts of data and provide valuable insights to surgeons. Furthermore, machine learning, imaging and sensing technology, teleoperation and telesurgery, and minimally invasive procedures are some of them. They require adoption oof proper skill and training for the medical staff and surgeons.

FutureWise Market Research has published a report that provides an insightful analysis of AI-based Surgical Robots Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that AI-based Surgical Robots Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Johnson & Johnson Services, Inc
  • Merck & Co., Inc
  • Cipla Limited
  • Sun Pharmaceuticals Industries Ltd
  • Dr. Reddy's Laboratoris Ltd
  • Glaxosmithkline Plc
  • Aurobindo Pharma
  • Viatris Inc
  • Pfizer Inc
  • Lilly
  • Lexington Intl., LLC
  • Freedom Laser Therapy
  • Curallux LLC
  • Apira Science Inc
  • Revian Inc
  • Theradome
  • Lutronic

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent advancement in AI based surgical robot’s market

  • Addition of the Hugo robotic – assisted surgery (RAS) system at hospital Clinico da la red de Salud UC CHRISTUS in Santiago, Chile, to assist the teaching institutions about new robotic surgery was announced by Medtronic plc, In July 2021

In healthcare, AI and robotics have proven to be priceless assets and are preferred by surgeons worldwide. AI-based robotic surgeries are established to be minimally invasive and result in creating a bloodless field as compared to standard surgical procedures. AI has wholly revolutionized modern-day practice in medical procedures with machine learning and simplifying the interaction between surgeons & robots. AI-assisted surgical robots help surgeons in a more accurate way for decision-making, speech recognition, and problem-solving, which is expected to increase their acceptance in the upcoming future. The shortage of medical professionals is a significant global concern, which is being recovered by using AI. It is further expected to boost the adoption of AI-based surgical robots, bolstering market growth. Furthermore, the rise in the trends to practice medical procedures using technology-based rather than conventional practices also foresee to drive market growth during the forecast period. Methods such as detecting cancer types, helping analyse scans & surgeries, and facilitating instrument positioning are done using great AI-based robotic instruments that again accelerate its adoption in healthcare institutions. Furthermore, the rise in the trends to practice medical procedures using technology-based rather than conventional practices also foresee to drive market growth during the forecast period. Methods such as detecting cancer types, helping analyse scans & surgeries, and facilitating instrument positioning are done using great AI-based robotic instruments that again accelerate its adoption in healthcare institutions. With numerous advantages comes certain restraining factors which include lack of skilled and trained knowledge based medical team and surgeons who need to take care of considering ethical and regulatory policies.
 

By Type

  • Alopecia Areata
    •   Male
    •   Female
  •  Cicatricial Alopecia
    •   Male
    •   Female
  •  Traction Alopecia
    •   Male
    •   Female
  •  Alopecia Totalis
    •   Male
    •   Female
  •  Alopecia Universalis
    •   Male 
    •   Female
  •  Androgenic Alopecia
    •   Male 
    •   Female
  •  Others
    •   Male 
    •   Female

By Treatment

  • Pharmaceuticals
  • Topical
  • OTC
  • Minoxidil

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America recorded the highest revenue share in 2022. In the U.S. increasing presence of major market players and ongoing AI-based robotic devices are also aiding in the growth. Furthermore, AI-equipped robot-assisted surgeries and the growing adoption of minimally invasive surgical procedures foresee accelerated market growth in North America. However, Asia Pacific is expected to register the fastest growth rate during the forecast period. With the increasing number of patients with chronic diseases and growing awareness, adopting minimally invasive automated robotic medical devices is a boon. Also, major players in the Asia Pacific region are expanding, which is further expected to boost growth. 

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the AI-based Surgical Robots Market By Product, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   AI-based Surgical Robots Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of AI-based Surgical Robots Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   AI-based Surgical Robots Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   AI-based Surgical Robots Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •         1. Alopecia Areata
         1.1. Male
         1.2. Female
        2. Cicatricial Alopecia
         2.1. Male
         2.2. Female
              3. Traction Alopecia
         3.1. Male
         3.2. Female
        4. Alopecia Totalis
         4.1. Male
         4.2. Female
             5. Alopecia Universalis
         5.1. Male
         5.2. Female
             6. Androgenic Alopecia
          6.1. Male
          6.2. Female
        7. Others
         7.1. Male
         7.2. Female
         

  • 8.   AI-based Surgical Robots Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceuticals
        2. Topical
        3. OTC
        4. Minoxidil

  • 9.   North America AI-based Surgical Robots Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America AI-based Surgical Robots Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe AI-based Surgical Robots Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific AI-based Surgical Robots Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •          1. Johnson & Johnson Services, Inc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Merck & Co., Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Cipla Limited
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Sun Pharmaceuticals Industries Ltd
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Dr. Reddy's Laboratoris Ltd
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Glaxosmithkline Plc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Aurobindo Pharma
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Viatris Inc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Pfizer Inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Lilly
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Lexington Intl., LLC
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Freedom Laser Therapy
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Curallux LLC
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14.Apira Science Inc
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15.Revian Inc
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16.Theradome
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17.Lutronic
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client

Related Market

AI-based Clinical Trials Solution Provider Market

Read More
Partner

Our Clients